Synribo
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Synribo, covering 2014-05-12 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) [Phase 1]